Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
2,036.26
2,164.80
1,925.80
2,022.46
2,233.32
2,054.89
2,035.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,036.26
2,164.80
1,925.80
2,022.46
2,233.32
2,054.89
2,035.58
Raw Material Cost
691.19
659.87
692.45
729.53
754.57
727.57
695.09
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.16
3.33
5.44
7.28
7.32
12.45
1.07
Selling and Distribution Expenses
642.62
856.27
788.73
827.21
857.10
799.00
861.12
Other Expenses
7.54
16.54
9.94
17.59
10.69
16.50
23.56
Total Expenditure (Excl Depreciation)
1,413.40
1,684.86
1,586.06
1,739.88
1,725.92
1,704.00
1,792.84
Operating Profit (PBDIT) excl Other Income
622.9
479.90000000000003
339.7
282.6
507.40000000000003
350.90000000000003
242.7
Other Income
50.05
19.45
52.84
49.52
32.66
66.37
50.30
Operating Profit (PBDIT)
745.88
587.49
366.60
421.18
613.18
503.74
188.86
Interest
4.16
3.33
5.44
7.28
7.32
12.45
1.07
Exceptional Items
-26.00
14.92
130.75
-14.38
35.43
42.18
42.58
Gross Profit (PBDT)
1,345.06
1,504.93
1,233.35
1,292.93
1,478.76
1,327.32
1,340.49
Depreciation
115.13
115.13
118.92
118.92
113.38
113.38
124.30
Profit Before Tax
600.59
483.95
372.99
280.60
527.90
420.08
106.06
Tax
64.84
96.97
123.68
45.36
38.97
75.88
41.21
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
522.44
370.24
120.59
209.68
460.39
314.31
113.38
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
522.44
370.24
120.59
209.68
460.39
314.31
113.38
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.45
-5.69
-51.80
-6.90
-2.70
17.78
-82.47
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
519.99
364.55
68.78
202.77
457.69
332.08
30.91
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
13,076.26
12,768.02
12,404.23
12,304.42
12,377.39
11,919.98
11,903.33
Earnings per share (EPS)
0.35
0.25
0.08
0.14
0.31
0.21
0.08
Diluted Earnings per share
0.35
0.25
0.08
0.14
0.31
0.21
0.08
Operating Profit Margin (Excl OI)
28.52%
20.92%
10.12%
12.5%
20.92%
15.77%
0.7%
Gross Profit Margin
35.15%
27.67%
25.54%
19.75%
28.71%
25.96%
11.32%
PAT Margin
25.66%
17.1%
6.26%
10.37%
20.61%
15.3%
5.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -5.94% vs 12.41% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 42.62% vs 429.94% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 22.50% vs 81.01% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 27.27% vs -38.89% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Tasly Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
2,036.26
0
2,036.26
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,036.26
0
2,036.26
Raw Material Cost
691.19
0
691.19
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.16
0
4.16
Selling and Distribution Expenses
642.62
0
642.62
Other Expenses
7.54
0.00
7.54
Total Expenditure (Excl Depreciation)
1,413.40
0
1,413.40
Operating Profit (PBDIT) excl Other Income
622.85
0.00
622.85
Other Income
50.05
0
50.05
Operating Profit (PBDIT)
745.88
0
745.88
Interest
4.16
0
4.16
Exceptional Items
-26.00
0
-26.00
Gross Profit (PBDT)
1,345.06
0
1,345.06
Depreciation
115.13
0
115.13
Profit Before Tax
600.59
0
600.59
Tax
64.84
0
64.84
Provisions and contingencies
0
0
0.00
Profit After Tax
522.44
0
522.44
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
522.44
0
522.44
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.45
0
-2.45
Other related items
0.00
0.00
0.00
Consolidated Net Profit
519.99
0
519.99
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
13,076.26
0
13,076.26
Earnings per share (EPS)
0.35
0
0.35
Diluted Earnings per share
0.35
0
0.35
Operating Profit Margin (Excl OI)
28.52%
0%
0.00
28.52%
Gross Profit Margin
35.15%
0%
0.00
35.15%
PAT Margin
25.66%
0%
0.00
25.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 203.63 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -5.94% vs 12.41% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -8.82% vs -3.87% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 52.00 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 42.62% vs 429.94% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 13.61% vs 27.14% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.58 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 22.50% vs 81.01% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 19.86% vs -9.20% in Jun 2025
Quarterly - Interest
Interest 0.42 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 27.27% vs -38.89% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -42.47% vs -63.13% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.52%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
